Magnetic seizure therapy for people with schizophrenia
References
Additional references
Allan CL, Ebmeier KP. The use of ECT and MST in treating depression. International Review of Psychiatry 2011;23(5):400‐12. [PUBMED: 22200130]
Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200.
American Psychiatric Association. The practice of ECT: recommendations for treatment, training and privileging. Convulsive Therapy 1990;6(2):85‐120. [PUBMED: 11659302]
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. Arlington, VA: American Psychiatric Publishing, 2013.
Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite]. Therapie 1999;54(4):405‐11. [PUBMED: 10667106]
Chan V. Schizophrenia and psychosis: diagnosis, current research trends, and model treatment approaches with implications for transitional age youth. Child and Adolescent Psychiatric Clinics of North America 2017;26(2):341‐66. [PUBMED: 28314460]
Chanpattana W, Kojima K, Kramer BA, Intakorn A, Sasaki S, Kitphati R. ECT practice in Japan. Journal of ECT 2005;21(3):139‐44. [PUBMED: 16127301]
Chanpattana W. A questionnaire survey of ECT practice in Australia. Journal of ECT 2007;23(2):89‐92. [PUBMED: 17548977]
Chanpattana W, Kramer BA, Kunigiri G, Gangadhar BN, Kitphati R, Andrade C. A survey of the practice of electroconvulsive therapy in Asia. Journal of ECT 2010;26(1):5‐10. [PUBMED: 19444137]
Cycowicz YM, Luber B, Spellman T, Lisanby SH. Differential neurophysiological effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS) in non‐human primates. Clinical EEG and Neuroscience 2008;39(3):144‐9. [PUBMED: 18751564]
Cycowicz YM, Luber B, Spellman T, Lisanby SH. Neurophysiological characterization of high‐dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes. Journal of ECT 2009;25(3):157‐64. [PUBMED: 19300292]
Deeks J. Issues in the selection for meta‐analyses of binary data. 8th International Cochrane Colloquium; 2000 Oct 25‐28; Cape Town. Cape Town: The Cochrane Collaboration, 2000.
Deeks JJ, Higgins JPT, Altman DG, editor(s). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
Deng ZD, Lisanby SH, Peterchev AV. Effect of anatomical variability on neural stimulation strength and focality in electroconvulsive therapy (ECT) and magnetic seizure therapy (MST). Engineering in Medicine and Biology Society 2009;2009:682‐8. [PUBMED: 19964484]
Deng ZD, Lisanby SH, Peterchev AV. Electric field strength and focality in electroconvulsive therapy and magnetic seizure therapy: a finite element simulation study. Journal of Neural Engineering 2011;8(1):016007. [PUBMED: 21248385]
Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623‐9.
Donner A, Klar N. Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971‐80.
Dwork AJ, Arango V, Underwood M, Ilievski B, Rosoklija G, Sackeim HA, et al. Absence of histological lesions in primate models of ECT and magnetic seizure therapy. American Journal of Psychiatry 2004;161(3):576‐8. [PUBMED: 14992989]
Dwork AJ, Christensen JR, Larsen KB, Scalia J, Underwood MD, Arango V, et al. Unaltered neuronal and glial counts in animal models of magnetic seizure therapy and electroconvulsive therapy. Neuroscience 2009;164(4):1557‐64. [PUBMED: 19782728]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34.
Eitan R, Lerer B. Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues in Clinical Neuroscience 2006;8(2):241‐58. [PUBMED: 16889109]
Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140‐9.
Fitzgerald PB, Hoy KE, Herring SE, Clinton AM, Downey G, Daskalakis ZJ. Pilot study of the clinical and cognitive effects of high‐frequency magnetic seizure therapy in major depressive disorder. Depression and Anxiety 2013;30(2):129‐36. [PUBMED: 23080404]
Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(7):7‐10.
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386(9995):743–800.
Gulliford MC. Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876‐83.
Guy W. Clinical Global Impression Scale. The ECDEU Assessment Manual for Psychopharmacology ‐ Revised. Rockville, MD: National Institute of Mental Health, 1976:218‐22.
Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960;23:56‐62. [PUBMED: 14399272]
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327:557‐60.
Higgins JPT, Green S, editor(s). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
Higgins JPT, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
Holtzheimer PE, Nemeroff CB. Advances in the treatment of depression. NeuroRx 2006;3(1):42‐56. [PUBMED: 16490412]
Hoy KE, Fitzgerald PB. Introducing magnetic seizure therapy: a novel therapy for treatment resistant depression. Australian and New Zealand Journal of Psychiatry 2010;44(7):591‐8. [PUBMED: 20560846]
Hoy KE, Fitzgerald PB. Magnetic seizure therapy for treatment‐resistant depression. Expert Review of Medical Devices 2011;8(6):723‐32. [PUBMED: 22029469]
Hutton JL. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology 2009;146(1):27‐30. [PUBMED: 19438480]
Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986.
Kayser S, Bewernick BH, Grubert C, Hadrysiewicz BL, Axmacher N, Schlaepfer TE. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment‐resistant depression. Journal of Psychiatric Research 2011;45(5):569‐76. [PUBMED: 20951997]
Kayser S, Bewernick BH, Hurlemann R, Soehle M, Schlaepfer TE. Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depression. European Neuropsychopharmacology 2013;23(11):1541‐50. [PUBMED: 23820052]
Kayser S, Bewernick BH, Matusch A, Hurlemann R, Soehle M, Schlaepfer TE. Magnetic seizure therapy in treatment‐resistant depression: clinical, neuropsychological and metabolic effects. Psychological Medicine 2015;45(5):1073‐92. [PUBMED: 25420474]
Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry 2004;161(2 Suppl):1‐56. [PUBMED: 15000267]
Leon AC, Mallinckrodt CH, Chuang‐Stein C, Archibald DG, Archer GE, Chartier K. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biological Psychiatry 2006;59(11):1001‐5. [PUBMED: 16905632]
Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophrenia Research 2005;79(2‐3):231‐8. [PUBMED: 15982856]
Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry 2005;187:366‐71. [PUBMED: 16199797]
Lisanby SH, Schlaepfer TE, Fisch HU, Sackeim HA. Magnetic seizure therapy of major depression. Archives of General Psychiatry2001; Vol. 58, issue 3:303‐5. [PUBMED: 11231838]
Lisanby SH, Luber B, Finck AD, Schroeder C, Sackeim HA. Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Archives of General Psychiatry2001; Vol. 58, issue 2:199‐200. [PUBMED: 11177122]
Lisanby SH. Update on magnetic seizure therapy: a novel form of convulsive therapy. Journal of ECT 2002;18(4):182‐8. [PUBMED: 12468992]
Lisanby SH, Luber B, Schlaepfer TE, Sackeim HA. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within‐subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003;28(10):1852‐65. [PUBMED: 12865903]
Lisanby SH, Morales O, Payne N, Kwon E, Fitzsimons L, Luber B, et al. New developments in electroconvulsive therapy and magnetic seizure therapy. CNS Spectrums 2003;8(7):529‐36. [PUBMED: 12894034]
Loo CK, Schweitzer I, Pratt C. Recent advances in optimizing electroconvulsive therapy. Australian and New Zealand Journal of Psychiatry 2006;40(8):632‐8. [PUBMED: 16866758]
Luber B, McClintock SM, Lisanby SH. Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging. Dialogues in Clinical Neuroscience 2013;15(1):87‐98. [PUBMED: 23576892]
Marder SR, Ames D, Wirshing WC, Van Putten T. Schizophrenia. Psychiatric Clinics of North America 1993;16(3):567‐87. [PUBMED: 8105452]
Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249‐52.
McClintock SM, DeWind NK, Husain MM, Rowny SB, Spellman TJ, Terrace H, et al. Disruption of component processes of spatial working memory by electroconvulsive shock but not magnetic seizure therapy. International Journal of Neuropsychopharmacology 2013;16(1):177‐87. [PUBMED: 22217479]
McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews 2008;30:67‐76. [PUBMED: 18480098]
Moksnes KM, Ilner SO. Electroconvulsive therapy‐‐efficacy and side‐effects. Tidsskrift for Den Norske Laegeforening 2010;130(24):2460‐4. [PUBMED: 21164584]
Mowla A, Sahraian A, Hushmand F, Hushmand F. Study the utilization and practice of ECT in South of Iran. Asian Journal of Psychiatry 2015;14:65‐6. [DOI: 10.1016/j.ajp.2015.02.002]
Noda Y, Daskalakis ZJ, Downar J, Croarkin PE, Fitzgerald PB, Blumberger DM. Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report. Neuropsychiatric Disease and Treatment 2014;10:2049‐55. [PUBMED: 25382978]
Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. American Journal of Psychiatry 2008;165(2):203‐13. [PUBMED: 18172019]
Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports 1962;10:799‐812.
Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet 2016;388(10039):86‐97. [PUBMED: 26777917]
Polster JD, Kayser S, Bewernick BH, Hurlemann R, Schlaepfer TE. Effects of electroconvulsive therapy and magnetic seizure therapy on acute memory retrieval. Journal of ECT 2015;31(1):13‐9. [PUBMED: 24853650]
Rau A, Grossheinrich N, Palm U, Pogarell O, Padberg F. Transcranial and deep brain stimulation approaches as treatment for depression. Clinical EEG and Neuroscience 2007;38(2):105‐15. [PUBMED: 17515176]
Rowny SB, Cycowicz YM, McClintock SM, Truesdale MD, Luber B, Lisanby SH. Differential heart rate response to magnetic seizure therapy (MST) relative to electroconvulsive therapy: a nonhuman primate model. Neuro Image 2009;47(3):1086‐91. [PUBMED: 19497373]
Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Available from www.cochrane‐handbook.org.
Spellman T, McClintock SM, Terrace H, Luber B, Husain MM, Lisanby SH. Differential effects of high‐dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biological Psychiatry 2008;63(12):1163‐70. [PUBMED: 18262171]
Sterne JAC, Egger M, Moher D, editor(s). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, et al. Definition and description of schizophrenia in the DSM‐5. Schizophrenia Research 2013;150(1):3‐10. [PUBMED: 23800613]
Tang YL, Jiang W, Ren YP, Ma X, Cotes RO, McDonald WM. Electroconvulsive therapy in China: clinical practice and research on efficacy. Journal of ECT 2012;28(4):206‐12. [PUBMED: 22801297]
Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD000076.pub2; PUBMED: 15846598]
Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area‐wide and organisation‐based interventions in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1‐75.
Weiner R, Lisanby SH, Husain MM, Morales OG, Maixner DF, Hall SE, et al. Electroconvulsive therapy device classification: response to FDA advisory panel hearing and recommendations. Journal of Clinical Psychiatry 2013;74(1):38‐42. [PUBMED: 23419224]
WHO. The ICD‐10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.
Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El‐Sayeh H, et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254‐7.
Xiang YT, Ungvari GS, Correll CU, Chiu HF, Lai KY, Wang CY, et al. Use of electroconvulsive therapy for Asian patients with schizophrenia (2001‐2009): trends and correlates. Psychiatry and Clinical Neurosciences 2015;69(8):489‐96. [PUBMED: 25708964]
